CLL-1 CAR-NK cells

CAR-NK therapy targeting CLL-1 (CLEC12A) · Shanghai General Hospital / Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLL-1 CAR-NK cells, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: CLL-1 CAR-NK Cells for Relapsed/Refractory AML [Phase 1]